Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype.
about
Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switchClinical significance of HIV-1 coreceptor usage.The biology of CCR5 and CXCR4Formal reasoning on qualitative models of coinfection of HIV and Tuberculosis and HAART therapyX4 viruses are frequently archived in patients with long-term HIV infection but do not seem to influence the "inflamm-aging" process.Modeling HIV quasispecies evolutionary dynamics.HIV-1 with multiple CCR5/CXCR4 chimeric receptor use is predictive of immunological failure in infected children.Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates.HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry.Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue.Increased sensitivity to broadly neutralizing antibodies of end-stage disease R5 HIV-1 correlates with evolution in Env glycosylation and charge.Adoption of an "open" envelope conformation facilitating CD4 binding and structural remodeling precedes coreceptor switch in R5 SHIV-infected macaques.Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use.Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS.Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis.Complexity and dynamics of HIV-1 chemokine receptor usage in a multidrug-resistant adolescentAn altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes.HIV-1 co-receptor usage: influence on mother-to-child transmission and pediatric infectionCD4-independent use of the CCR5 receptor by sequential primary SIVsm isolatesIndependent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue.Advances in human immunodeficiency virus therapeutics.Identification of interdependent variables that influence coreceptor switch in R5 SHIV(SF162P3N)-infected macaques.Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma virusesEvolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression.Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5.Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain.Human immunodeficiency virus type 1 V1-to-V5 envelope variants from the chronic phase of infection use CCR5 and fuse more efficiently than those from early after infection.Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc.Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications.Adaptation of HIV-1 to cells with low expression of the CCR5 coreceptor.Thymic pathogenicity of an HIV-1 envelope is associated with increased CXCR4 binding efficiency and V5-gp41-dependent activity, but not V1/V2-associated CD4 binding efficiency and viral entry.Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance.Emergence of CD134 cysteine-rich domain 2 (CRD2)-independent strains of feline immunodeficiency virus (FIV) is associated with disease progression in naturally infected cats.Evolution of CCR5 use before and during coreceptor switchingReduced Baseline Sensitivity to Maraviroc Inhibition Among R5 HIV-1 Isolates From Individuals With Severe Immunodeficiency.Sequence analysis of HIV-1 isolates from Guinea-Bissau: selection of vaccine epitopes relevant in both West African and European countries.
P2860
Q24672335-9381E2EC-FD7A-4A44-930D-16D50F462941Q27691426-639CCDCF-F299-43E8-A713-1A0777EC86BFQ29012920-7154EB1C-9AA5-4715-937B-3E0375C95992Q30385211-109BF8A6-81C3-4371-B0DD-BE2E96F1B14EQ31117473-713F38F7-D511-4729-916C-BCE2D6A8429DQ33296550-C7860097-1DB8-480B-A87E-2058CBB5E4E0Q33372329-35BAE814-E366-4B70-BFD8-EA96AC164D80Q33686847-36B574B1-D368-44D3-9127-50F79F41929DQ33807529-1C07867C-4BD5-4A9C-B1F4-38ABB8989F01Q33930335-EF204F2D-E0F9-4412-828A-D0D0B29F48EDQ33941033-0BBF51B6-E1E2-4DCE-977F-955F385B130FQ33961448-BDDCA938-DB7A-4890-BB11-E678B3A51A48Q33961704-9A91DF21-CC6E-433B-A006-225A52105CBDQ34008699-83EF8476-4D1C-45C0-9C41-F84472A767D2Q34170655-38D96748-4E6A-45A7-A243-8CAE65CB2BFCQ34606488-114376BC-B0CC-4B64-917C-89FA2F2C8182Q34987062-6C84A85F-AC06-4DA9-9E12-1B8F5F62A0FFQ35018123-3AC65E57-265F-4B3F-B6CB-6F835AFDAA89Q35946467-4FDFC73C-A315-454D-8B28-B09687E4ED5DQ35996364-9066B6A7-D1FB-4DFA-9DE4-AA2D730F22A7Q36427662-8B6E8B9B-9FC2-4CC3-BAF0-21CCEADFD573Q36484034-17E4F571-09A3-4974-947C-16F37B69CA14Q36502557-225A73DE-7CB5-4DA8-89E6-0F4B67A3847EQ36580487-7BFFFE3D-30B9-4B2B-9A2A-6682A6C74A8DQ36607127-B0B003ED-B9A8-4B3B-A9CA-3A0E5A9BE941Q37191794-29754191-407C-49A4-AE9F-0EC9E6794C51Q37356028-63ED84AA-5F84-4D83-B3B9-BC691406AA5AQ37390786-04F24FC7-D022-48C7-9CEC-11DCDCA29162Q38645990-DF7FCF36-7296-41C9-88D4-F3272A4960DDQ38703060-602DC8AD-2F86-4CF5-AA48-39499A2090BDQ39242155-6285E7F0-5711-4B11-BFD1-018C838B082AQ39471859-F62769A8-834C-4BEC-AD2E-71C5A30418BAQ41645414-9FD6186F-28FC-41EA-B795-61B4E9B24AE9Q41995185-0E79000E-00B9-438A-A611-523DEEE9E414Q42600049-B63397D3-7292-4FA7-8CCF-021120A0B46FQ44216622-08606EF7-CFA2-4784-A900-9258F4825A1A
P2860
Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Coevolution of RANTES sensitiv ...... us type 1 of the R5 phenotype.
@en
type
label
Coevolution of RANTES sensitiv ...... us type 1 of the R5 phenotype.
@en
prefLabel
Coevolution of RANTES sensitiv ...... us type 1 of the R5 phenotype.
@en
P2093
P2860
P1433
P1476
Coevolution of RANTES sensitiv ...... us type 1 of the R5 phenotype.
@en
P2093
Anders Karlsson
Björn Olde
Christer Owman
Ingrid Karlsson
Jan Albert
Liselotte Antonsson
Monica Oberg
P2860
P304
11807-11815
P356
10.1128/JVI.78.21.11807-11815.2004
P407
P577
2004-11-01T00:00:00Z